Compare Stocks → the most reliable asset on earth is making a comeback (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:ALSCVE:ATMNYSE:BMNCVE:EMH Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALSAltius MineralsC$20.47+1.3%C$18.33C$16.11▼C$23.00C$958.20M0.9385,196 shs59,655 shsATMRio2C$0.68+1.5%C$0.68C$0.57▼C$0.86C$57.62MN/A114,654 shs15,000 shsBMNBlackrock 2037 Municipal Target Term Trust$24.24$24.03$21.51▼$25.59N/AN/A25,359 shs22,353 shsEMHEmerald Health TherapeuticsC$0.26-3.8%C$0.26C$0.15▼C$0.53C$52.28MN/A644,760 shs384,329 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALSAltius Minerals+1.34%-0.82%+21.34%+10.53%-4.66%ATMRio20.00%0.00%0.00%0.00%0.00%BMNBlackrock 2037 Municipal Target Term Trust0.00%+0.66%+1.34%+2,423,999,900.00%+2,423,999,900.00%EMHEmerald Health Therapeutics0.00%0.00%0.00%0.00%0.00%Your $200 account credit is about to expire (Ad)Update to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial HereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALSAltius Minerals1.4976 of 5 stars2.40.00.80.01.82.51.3ATMRio2N/AN/AN/AN/AN/AN/AN/AN/ABMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALSAltius Minerals2.80Moderate BuyC$23.1312.97% UpsideATMRio2N/AN/AN/AN/ABMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/AN/AN/AN/ACurrent Analyst RatingsLatest BMN, ATM, ALS, and EMH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/12/2024ALSAltius MineralsTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ BuyC$22.00 ➝ C$23.002/6/2024ALSAltius MineralsScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSector PerformC$20.00 ➝ C$18.501/24/2024ALSAltius MineralsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetC$25.00 ➝ C$24.001/8/2024ALSAltius MineralsNational BanksharesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperformC$24.00 ➝ C$23.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALSAltius MineralsC$68.96M13.90C$1.90 per share10.80C$10.38 per share1.97ATMRio2N/AN/AN/AN/AN/AN/ABMNBlackrock 2037 Municipal Target Term Trust$11.91MN/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsC$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALSAltius MineralsC$9.54MC$0.20102.35∞N/A13.83%1.66%2.46%5/13/2024 (Estimated)ATMRio2N/AN/A0.00∞N/AN/AN/AN/AN/ABMNBlackrock 2037 Municipal Target Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/AEMHEmerald Health TherapeuticsN/A-C$0.70N/A∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALSAltius MineralsC$0.321.56%N/A160.00%N/AATMRio2N/AN/AN/AN/AN/ABMNBlackrock 2037 Municipal Target Term Trust$1.124.62%N/AN/A1 YearsEMHEmerald Health TherapeuticsN/AN/AN/AN/AN/ALatest BMN, ATM, ALS, and EMH DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/11/2024ALSAltius MineralsQuarterlyC$0.081.56%3/15/20243/18/20244/1/20243/1/2024BMNBlackrock 2037 Municipal Target Term TrustMonthly$0.09404.72%3/14/20243/15/20244/1/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALSAltius Minerals18.3811.236.49ATMRio2N/AN/AN/ABMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AEMHEmerald Health Therapeutics35.452.972.61OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALSAltius Minerals24.07%ATMRio2N/ABMNBlackrock 2037 Municipal Target Term TrustN/AEMHEmerald Health TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipALSAltius Minerals18.72%ATMRio2N/ABMNBlackrock 2037 Municipal Target Term TrustN/AEMHEmerald Health TherapeuticsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableALSAltius Minerals1946.81 millionN/ANot OptionableATMRio2N/A84.74 millionN/ANot OptionableBMNBlackrock 2037 Municipal Target Term TrustN/AN/AN/AN/AEMHEmerald Health Therapeutics161205.03 millionN/ANot OptionableBMN, ATM, ALS, and EMH HeadlinesSourceHeadlineUniversity Hospitals Elyria Medical Centerhealth.usnews.com - September 23 at 12:26 AMDigital Therapeutics: Next wave in managing chronic medical conditionshealth.economictimes.indiatimes.com - September 13 at 9:19 PMThe Digital Therapeutics Market Is Gangbustersmddionline.com - August 29 at 11:45 PMDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Studyfinance.yahoo.com - July 31 at 12:17 AMEmerald Isle’s Lee Avenue to close again soon as culvert project restartscarolinacoastonline.com - July 15 at 8:44 AMEfficient Market Hypothesis (EMH): Definition and Critiqueinvestopedia.com - July 12 at 2:56 PMRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solutionfinance.yahoo.com - June 20 at 12:36 PMMenarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023thaipr.net - May 29 at 4:23 AMEmerald Care Center Tulsahealth.usnews.com - May 4 at 11:26 PMEmerald Reeghealth.usnews.com - April 25 at 7:35 AMEmerald Expositions GAAP EPS of $0.06, revenue of $93.6Mmsn.com - March 14 at 9:07 AMTahoe's Emerald Bay freezes over for first time in decades amid atmospheric riversfgate.com - March 13 at 4:02 AMVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conferenceventurebeat.com - March 4 at 6:25 PMEmerald community raising money for local dialysis services after political campaigns failabc.net.au - February 25 at 12:07 AMNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgiamddionline.com - February 22 at 11:25 PMEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Yearfinance.yahoo.com - January 14 at 1:43 PMEmerald Health Therapeutics Inc (TBD.BE)finance.yahoo.com - January 4 at 3:42 AMEmerald Health Therapeutics Announces Revocation of Management Cease Trade Orderfinance.yahoo.com - July 12 at 9:36 AMEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Updatefinance.dailyherald.com - July 4 at 7:56 AMEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Updatefinance.yahoo.com - June 16 at 8:02 AMEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Updatestockhouse.com - May 16 at 4:37 PMSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeuticsnz.finance.yahoo.com - May 12 at 9:26 AMCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBinvestorideas.com - May 6 at 10:47 AMEmperor Oil Ltd (EMh)investing.com - January 5 at 8:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlinesbluebird bio Stock Signals Potential to be a Multi-bagger February 29, 2024 9:55 AMView bluebird bio Stock Signals Potential to be a Multi-bagger SoFi Presents Another Entry Opportunity for InvestorsMarch 19, 2024 7:32 AMView SoFi Presents Another Entry Opportunity for InvestorsJabil Stock Implodes: Market Manufactures Entry for New MoneyMarch 15, 2024 11:46 AMView Jabil Stock Implodes: Market Manufactures Entry for New Money3 Mining Stocks to Explode This Year on a Commodity Price SwingMarch 4, 2024 6:08 AMView 3 Mining Stocks to Explode This Year on a Commodity Price Swingbluebird bio: How to play LEAPS options for growth and income February 27, 2024 8:00 AMView bluebird bio: How to play LEAPS options for growth and income All Headlines Company DescriptionsAltius MineralsTSE:ALSAltius Minerals Corporation operates as a diversified mining royalty and streaming company in Canada, the United States, and Brazil. The company owns royalty and streaming interests in 11 operating mines covering copper, zinc, nickel, cobalt, potash, iron ore, precious metals, and thermal and metallurgical coal. It is also involved in the acquisition and management of renewable energy investments and royalties, as well as early-stage royalties and minority equity or project interests. Altius Minerals Corporation was incorporated in 1997 and is headquartered in St. John's, Canada.Rio2CVE:ATMAtacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.Blackrock 2037 Municipal Target Term TrustNYSE:BMNBlackrock 2037 Municipal Target Term Trust is an close-ended fixed income mutual fund launched by Blackrock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in fixed income markets. The fund primarily invests in n investment grade municipal securities that are rated BBB- or above by S&P and Fitch or Baa3 or above by Moody's. Blackrock 2037 Municipal Target Term Trust is domiciled in the United States.Emerald Health TherapeuticsCVE:EMHEmerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.